These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25722721)

  • 1. Corrigendum to "Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest".
    Duangmano S; Sae-Lim P; Suksamrarn A; Patmasiriwat P; Domann FE
    J Oncol; 2015; 2015():486850. PubMed ID: 25722721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest.
    Duangmano S; Sae-Lim P; Suksamrarn A; Patmasiriwat P; Domann FE
    J Oncol; 2012; 2012():601682. PubMed ID: 22690217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.
    Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ
    Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2alpha in leukemia cells.
    Li Y; Wang R; Ma E; Deng Y; Wang X; Xiao J; Jing Y
    Anticancer Drugs; 2010 Apr; 21(4):389-400. PubMed ID: 20110807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer.
    Kim HJ; Park JH; Kim JK
    Chem Biol Interact; 2014 Aug; 219():1-8. PubMed ID: 24858077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells.
    Alafnan A; Khalifa NE; Hussain T; Osman ME
    Front Pharmacol; 2023; 14():1286507. PubMed ID: 37841925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
    Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W
    Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure.
    DeWeese TL; Shipman JM; Dillehay LE; Nelson WG
    J Urol; 1998 Feb; 159(2):591-8. PubMed ID: 9649298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells.
    Tannin-Spitz T; Grossman S; Dovrat S; Gottlieb HE; Bergman M
    Biochem Pharmacol; 2007 Jan; 73(1):56-67. PubMed ID: 17049494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum:
    Wu D; Wang Z; Lin M; Shang Y; Wang F; Zhou J; Wang F; Zhang X; Luo X; Huang W
    Front Pharmacol; 2024; 15():1334971. PubMed ID: 38505422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 25-O-acetyl-23,24-dihydro-cucurbitacin F induces cell cycle G2/M arrest and apoptosis in human soft tissue sarcoma cells.
    Lohberger B; Kretschmer N; Bernhart E; Rinner B; Stuendl N; Kaltenegger H; Kahl S; Bauer R; Leithner A
    J Ethnopharmacol; 2015 Apr; 164():265-72. PubMed ID: 25701753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sestrin-3 modulation is essential for therapeutic efficacy of cucurbitacin B in lung cancer cells.
    Khan N; Jajeh F; Khan MI; Mukhtar E; Shabana SM; Mukhtar H
    Carcinogenesis; 2017 Feb; 38(2):184-195. PubMed ID: 27881463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin B induces DNA damage, G2/M phase arrest, and apoptosis mediated by reactive oxygen species (ROS) in leukemia K562 cells.
    Guo J; Zhao W; Hao W; Ren G; Lu J; Chen X
    Anticancer Agents Med Chem; 2014; 14(8):1146-53. PubMed ID: 24893803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells.
    Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J
    Cell Biol Toxicol; 2008 Oct; 24(5):401-9. PubMed ID: 18224451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of
    Aiswarya SUD; Vikas G; Haritha NH; Liju VB; Shabna A; Swetha M; Rayginia TP; Keerthana CK; Nath LR; Reshma MV; Sundaram S; Anto NP; Lankalapalli RS; Anto RJ; Bava SV
    Front Oncol; 2022; 12():989283. PubMed ID: 36033534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.
    Yin D; Wakimoto N; Xing H; Lu D; Huynh T; Wang X; Black KL; Koeffler HP
    Int J Cancer; 2008 Sep; 123(6):1364-75. PubMed ID: 18561312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of cucurbitacin-A in ovarian cancer cell line SKOV3 involves cell cycle arrest, apoptosis and inhibition of mTOR/PI3K/Akt signaling pathway.
    Liu J; Liu X; Ma W; Kou W; Li C; Zhao J
    J BUON; 2018; 23(1):124-128. PubMed ID: 29552771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells.
    Choi EJ; Kim GH
    Phytomedicine; 2008 Sep; 15(9):683-90. PubMed ID: 18541420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pectenotoxin-2 induces G2/M phase cell cycle arrest in human breast cancer cells via ATM and Chk1/2-mediated phosphorylation of cdc25C.
    Moon DO; Kim MO; Nam TJ; Kim SK; Choi YH; Kim GY
    Oncol Rep; 2010 Jul; 24(1):271-6. PubMed ID: 20514472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.